Dynepo

DRUG2 trials

Sponsors

Shire

Conditions

AnemiaKidney FailureKidney Failure, Chronic

Phase 3

Dynepo Infrequent Dosing Study

TerminatedNCT00450333

ShireAnemia, Kidney Failure

Start: 2006-10-30End: 2008-07-31Updated: 2021-06-14

Phase 4

Dynepo Long-Term Safety Study

TerminatedNCT00514813

ShireAnemia, Kidney Failure, Chronic

Start: 2007-06-06End: 2008-07-31Updated: 2021-07-13

Related Papers

Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial.

2007-11-134 citations